Can Anti-Metastatic Albumin-based Superoxide Dismutase Mimetic Serve as a "Moonshot" Drug for Treatment for Brain Tumors - From Medulloblastoma to Glioblastoma?

Cell Biochem Biophys. 2019 Jun;77(2):121-122. doi: 10.1007/s12013-019-00869-2. Epub 2019 May 15.

Authors

Carleton J C Hsia¹, Shanta M Messerli², W Keith Miskimins³

Affiliations

¹ AntiRadical Therapeutics LLC, Sioux Falls, SD, 57104, USA. chsia@nanorbc.com.
² Cancer Biology and Immunotherapies, Sanford Research, Sioux Falls, SD, 57104, USA.
³ Cancer Biology and Immunotherapies, Sanford Research, Sioux Falls, SD, 57104, USA. keith.miskimins@sanfordhealth.org.

PMID: 31093886
DOI: 10.1007/s12013-019-00869-2

No abstract available

MeSH terms

Albumins
Brain Neoplasms*
Glioblastoma*
Humans
Medulloblastoma*
Superoxide Dismutase

Substances

Albumins
Superoxide Dismutase

Grants and funding